NRBF2-CYP26A1 Fusion FISH Probe
The NRBF2-CYP26A1 Fusion FISH Probe is used to confirm a fusion of the NRBF2 and CYP26A1 genes. The fusion of the NRBF2 and CYP26A1 genes has been associated with Breast Invasive Carcinoma. These probes are FISH confirmed on normal peripheral blood in both interphase nuclei and metaphase spreads before shipment. Typical turnaround time for this product is 7-14 days after purchase.
** This product is for in vitro and research use only. This product is not intended for diagnostic use. Please note that both genes fall on the same chromosome and inter-chromosomal detection may be difficult to detect depending on the genes proximity to one another. Please consult our support staff before ordering this product to ensure that the probe can be designed to meet your specific needs.
| SKU | Test Kits | Buffer | Dye Color | Order Now |
|---|---|---|---|---|
| NRBF2-CYP26A1-20-ORGR (Standard Design) | 20 (40 μL) | 200 μL |
|
|
| NRBF2-CYP26A1-20-RERE | 20 (40 μL) | 200 μL |
|
|
| NRBF2-CYP26A1-20-REOR | 20 (40 μL) | 200 μL |
|
|
| NRBF2-CYP26A1-20-REGO | 20 (40 μL) | 200 μL |
|
|
| NRBF2-CYP26A1-20-REGR | 20 (40 μL) | 200 μL |
|
|
| NRBF2-CYP26A1-20-REAQ | 20 (40 μL) | 200 μL |
|
|
| NRBF2-CYP26A1-20-ORRE | 20 (40 μL) | 200 μL |
|
|
| NRBF2-CYP26A1-20-OROR | 20 (40 μL) | 200 μL |
|
|
| NRBF2-CYP26A1-20-ORGO | 20 (40 μL) | 200 μL |
|
|
| NRBF2-CYP26A1-20-ORAQ | 20 (40 μL) | 200 μL |
|
|
| NRBF2-CYP26A1-20-GORE | 20 (40 μL) | 200 μL |
|
|
| NRBF2-CYP26A1-20-GOOR | 20 (40 μL) | 200 μL |
|
|
| NRBF2-CYP26A1-20-GOGO | 20 (40 μL) | 200 μL |
|
|
| NRBF2-CYP26A1-20-GOGR | 20 (40 μL) | 200 μL |
|
|
| NRBF2-CYP26A1-20-GOAQ | 20 (40 μL) | 200 μL |
|
|
| NRBF2-CYP26A1-20-GRRE | 20 (40 μL) | 200 μL |
|
|
| NRBF2-CYP26A1-20-GROR | 20 (40 μL) | 200 μL |
|
|
| NRBF2-CYP26A1-20-GRGO | 20 (40 μL) | 200 μL |
|
|
| NRBF2-CYP26A1-20-GRGR | 20 (40 μL) | 200 μL |
|
|
| NRBF2-CYP26A1-20-GRAQ | 20 (40 μL) | 200 μL |
|
|
| NRBF2-CYP26A1-20-AQRE | 20 (40 μL) | 200 μL |
|
|
| NRBF2-CYP26A1-20-AQOR | 20 (40 μL) | 200 μL |
|
|
| NRBF2-CYP26A1-20-AQGO | 20 (40 μL) | 200 μL |
|
|
| NRBF2-CYP26A1-20-AQGR | 20 (40 μL) | 200 μL |
|
|
| NRBF2-CYP26A1-20-AQAQ | 20 (40 μL) | 200 μL |
|
CYP26A1 Gene Summary
This gene encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This endoplasmic reticulum protein acts on retinoids, including all-trans-retinoic acid (RA), with both 4-hydroxylation and 18-hydroxylation activities. This enzyme regulates the cellular level of retinoic acid which is involved in regulation of gene expression in both embryonic and adult tissues. Two alternatively spliced transcript variants of this gene, which encode the distinct isoforms, have been reported. [provided by RefSeq, Jul 2008]
Gene Name: Cytochrome P450 Family 26 Subfamily A Member 1
Chromosome: CHR10: 94833231 -94837641
Locus: 10q23.33
NRBF2 Gene Summary
The Nuclear Receptor Binding Factor 2 (NRBF2) gene is located on chr10 :64893006-64914786 at 10q21.3.
Gene Name: Nuclear Receptor Binding Factor 2
Chromosome: CHR10: 64893006 -64914786
Locus: 10q21.3
Gene Diseases
The NRBF2 CYP26A1 Fusion has been associated with the following diseases:
| Disease Name |
|---|
| Breast Invasive Carcinoma |
FISH Probe Protocols
| Protocol, Procedure, or Form Name | Last Modified | Download |
|---|